NL128816C - - Google Patents

Info

Publication number
NL128816C
NL128816C NL128816DA NL128816C NL 128816 C NL128816 C NL 128816C NL 128816D A NL128816D A NL 128816DA NL 128816 C NL128816 C NL 128816C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL128816C publication Critical patent/NL128816C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/0035Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Machines (AREA)
NL128816D 1965-04-22 NL128816C (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB17027/65A GB1077392A (en) 1965-04-22 1965-04-22 New steroids
GB3586565 1965-08-20

Publications (1)

Publication Number Publication Date
NL128816C true NL128816C (en:Method)

Family

ID=26252388

Family Applications (3)

Application Number Title Priority Date Filing Date
NL128816D NL128816C (en:Method) 1965-04-22
NL6605174A NL6605174A (en:Method) 1965-04-22 1966-04-18
NL6605375A NL6605375A (en:Method) 1965-04-22 1966-04-21

Family Applications After (2)

Application Number Title Priority Date Filing Date
NL6605174A NL6605174A (en:Method) 1965-04-22 1966-04-18
NL6605375A NL6605375A (en:Method) 1965-04-22 1966-04-21

Country Status (15)

Country Link
US (2) US3413286A (en:Method)
AT (2) AT265539B (en:Method)
BE (2) BE679821A (en:Method)
BR (2) BR6678805D0 (en:Method)
CH (2) CH471833A (en:Method)
DE (3) DE1793662C3 (en:Method)
DK (2) DK116870B (en:Method)
ES (1) ES325755A1 (en:Method)
FI (2) FI44906C (en:Method)
FR (1) FR5645M (en:Method)
GB (1) GB1077392A (en:Method)
IL (2) IL25493A (en:Method)
NL (3) NL6605174A (en:Method)
NO (2) NO127346B (en:Method)
SE (2) SE323675B (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1119081A (en) * 1966-01-11 1968-07-10 Lepetit Spa New steroids
IT1141930B (it) * 1980-04-28 1986-10-08 Lepetit Spa Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche
IT1134455B (it) * 1980-11-26 1986-08-13 Lepetit Spa Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnanici
WO2005021515A2 (en) * 2003-08-29 2005-03-10 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
CA2626628A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type iv inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CN101177443B (zh) * 2006-11-09 2011-08-03 天津药业研究院有限公司 新的甾体化合物及其应用
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
EP2124943A1 (en) * 2007-03-14 2009-12-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors
CN103497185A (zh) 2007-03-14 2014-01-08 兰贝克赛实验室有限公司 用作磷酸二酯酶抑制剂的吡唑并(3,4-b)吡啶衍生物
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2874154A (en) * 1954-10-15 1959-02-17 Syntex Sa Process for the production of 20-keto-21-iodo steroids
US2923721A (en) * 1955-12-13 1960-02-02 Lab Francais Chimiotherapie Method of preparing 3-keto delta1, 4 steroids
DE1223376B (de) * 1963-12-14 1966-08-25 Hoechst Ag Verfahren zur Herstellung von 17alpha-Cyan-16alpha-hydroxy-steroiden der Pregnanreihe
US3349084A (en) * 1965-05-17 1967-10-24 Upjohn Co Steroidal [16, 17-d]-2'-isoxazolines of the pregnane series

Also Published As

Publication number Publication date
US3413286A (en) 1968-11-26
IL25494A (en) 1970-03-22
DE1793662B2 (de) 1973-04-19
FR5645M (en:Method) 1967-12-26
NO128152B (en:Method) 1973-10-08
US3436389A (en) 1969-04-01
BR6679615D0 (pt) 1973-10-23
CH453351A (fr) 1968-06-14
FI44905C (fi) 1972-02-10
SE323674B (en:Method) 1970-05-11
NL6605375A (en:Method) 1966-10-24
DE1568950A1 (de) 1970-11-26
DK117631B (da) 1970-05-19
BE679821A (en:Method) 1966-10-03
BE679820A (en:Method) 1966-10-03
AT265539B (de) 1968-10-10
NO127346B (en:Method) 1973-06-12
IL25493A (en) 1969-12-31
SE323675B (en:Method) 1970-05-11
CH471833A (fr) 1969-04-30
DE1793662C3 (de) 1973-11-08
FI44906C (fi) 1972-02-10
DE1568951A1 (de) 1970-06-18
BR6678805D0 (pt) 1973-09-18
DE1793662A1 (de) 1972-08-03
NL6605174A (en:Method) 1966-10-24
FI44906B (en:Method) 1971-11-01
FI44905B (en:Method) 1971-11-01
AT260440B (de) 1968-03-11
GB1077392A (en) 1967-07-26
DK116870B (da) 1970-02-23
ES325755A1 (es) 1967-02-16

Similar Documents

Publication Publication Date Title
FI44905B (en:Method)
BE675606A (en:Method)
BE675671A (en:Method)
BE663916A (en:Method)
BE664754A (en:Method)
BE665833A (en:Method)
BE666471A (en:Method)
BE666660A (en:Method)
BE667205A (en:Method)
BE667746A (en:Method)
BE667950A (en:Method)
BE668005A (en:Method)
BE668137A (en:Method)
BE668330A (en:Method)
BE668816A (en:Method)
BE671633A (en:Method)
BE671964A (en:Method)
BE672779A (en:Method)
BE673071A (en:Method)
BE673453A (en:Method)
BE673690A (en:Method)
BE673860A (en:Method)
BE674302A (en:Method)
BE674403A (en:Method)
BE674655A (en:Method)